A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

NCT00787202 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: CP- 690 550
DRUG: CP- 690 550
DRUG: CP- 690 550
DRUG: CP- 690 550
OTHER: placebo

Sponsor

Pfizer